Bacillus velezensis and application thereof in degrading tobacco-specific nitrosamine NNK

Through the directional degradation of tobacco products by Bacillus 14-NW and combined with molecular sieve treatment, the problem of difficulty in reducing the NNK content of tobacco unique nitrosamines in the prior art is solved, and the protection of tobacco quality and effective degradation of NNK is achieved. Meet health standards.

CN119060874APending Publication Date: 2024-12-03SHENZHEN SMOORE TECH LTD
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202410893337.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-03
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The prior art is difficult to effectively reduce the content of tobacco-specific nitrosamine NNK, especially without affecting the quality of tobacco and introducing other harmful substances. In addition, agricultural technology requires long-term cultivation of new tobacco varieties, and there is a risk of using chemical inhibitors.

Method used

Bacillus velezensis 14-NW was used to direct degradation of tobacco products through its metabolic enzymes, reduce the NNK content, and combine molecular sieves as biological agents to perform tobacco treatment to simulate the tobacco leaf alcoholization process.

Benefits of technology

It has achieved complete degradation of NNK in tobacco products, reduced the content of harmful substances in tobacco products, ensured the excellent quality of tobacco, and met the World Health Organization's recommended standards for NNK intake.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004929985260000091
    Figure BDA0004929985260000091
  • Figure BDA0004929985260000101
    Figure BDA0004929985260000101
  • Figure BDA0004929985260000102
    Figure BDA0004929985260000102
Patent Text Reader

Abstract

The invention belongs to the technical field of bioengineering. In particular to bacillus velezensis and application of the bacillus velezensis to degradation of tobacco-specific nitrosamine NNK. The invention provides bacillus velezensis 14-NW, and the bacillus velezensis 14-NW is characterized in that the preservation number of the bacillus velezensis 14-NW is as follows. The bacillus velezensis 14-NW can act on tobacco products, the content of NNK of the tobacco products can be directionally reduced, and the NNK can be directionally and completely degraded at most without introducing other harmful substances.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of bioengineering technology and specifically relates to a Bacillus velez and its use in degrading tobacco-specific nitrosamine NNK. Background Art

[0002] TSNAs (Tobacco-specific nitrosamines, TSNAs) are a class of organic compounds containing pyridine rings and nitrosamine structures, and are unique carcinogens in tobacco. There are seven types of nitrosamines in tobacco smoke: N-nitrosonornicotine (NNN), N-nitrosonenicotine (NAT), N-nitrosoanabasine (NAB), 4-(N-methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), 4-(N-methyl-N-nitrosamino)-4-(3-pyridyl)butyraldehyde (NNA), 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and 4-(N-methyl-N-nitrosamino)-4-(3-pyridyl)-1-butanol (iso-NNAL). In 1963, it was first reported that NAB induced benign esophageal tumors in a certain type of mouse. Both NNN and NNK are strong animal carcinogens, inducing lung cancer in mice, rats and Syrian golden voles. In metabolic activities, NNK methylates DNA in living animals and human tissues in vitro. It can be proved from 07-methylguanine and 06-methylguanine isolated from human tissues that DNA with 06-methylguanine in the genetic code may cause cancer. In addition, it was found that when mice were fed a high-fat diet, NNK could induce an increase in the activity of cyclooxygenase-2, leading to cancer. Therefore, reducing the content of NNK and NNN in flue gas is the key to current research.

[0003] In recent years, the degradation of tobacco-specific nitrosamines has achieved certain results. In terms of agricultural technology, new tobacco varieties with low nitrosamines and low nicotine have been cultivated by destroying the expression of quinolinate ribosyltransferase (OPTase) gene; the use of bud inhibitor (1,2-dihydro-3,6-pyridazine dione, referred to as MH), VE (α-tocopherol) and VC (vitamin C) can reduce the TSNAs content and nitrite content. In terms of curing technology, the use of heat exchangers instead of direct ovens to bake tobacco leaves can reduce the average TSNAs content in flue-cured tobacco by at least 80%; nitrite inhibitors such as VC and VE are added during the curing process. In addition, improving the curing process can also reduce TSNAs. In the curing process of reconstituted tobacco leaves, soluble proteins, polyphenols, excessive nitrates, alkaloids, pesticide residues, etc. can be removed, and other reagents can also be added, so that the amount of TSNAs can be eliminated to the maximum extent; the use of microwave radiation can effectively kill harmful bacteria that produce TSNAs during the curing process of tobacco leaves, thereby inhibiting the formation and accumulation of TSNAs. In terms of biotechnology, hemoglobin can significantly intercept TSNAs in smoke. Hemoglobin was extracted from animal blood and added to cigarettes as a filter additive. The results showed that the content of TSNAs in smoke was significantly reduced. Endogenous bacteria were used to modulate the mixture in three ways: crushed tobacco leaves, petiole soaking and leaf spraying. The results showed that inoculation of endophytic bacteria could reduce the content of TSNAs by 27.56% to 99.8%. In terms of agricultural technology, it takes a long time to cultivate plants, which is not conducive to product development. Adding chemical inhibitors may cause other toxic substances to enter tobacco products. The method of hemoglobin and white protein interception will increase the protein content in tobacco and affect the smoking quality. Therefore, finding microorganisms that degrade TSNAs and conducting microbial treatment is the best feasible solution. According to the NNK intake recommended by the World Health Organization, the NNK in smoke should be less than 0.07ng / 100 puffs.

[0004] Therefore, there is a need in the art for a microorganism that can degrade TSNAs in a targeted manner, and utilizes the microorganism to process tobacco extracts and tobacco leaves, simulating the process of tobacco leaf aging, thereby ensuring the original quality of the tobacco, not introducing other harmful substances, and removing TSNAs in a targeted manner. Summary of the invention

[0005] In view of this, in a first aspect, the present invention provides a Bacillus velezensis 14-NW, characterized in that its deposit number is CGMCC No.30771.

[0006] The Bacillus Velez 14-NW described in the present invention was deposited in the General Microbiology Center of the China Microorganism Culture Collection Administration (CGMCC for short) on May 24, 2024, with the deposit number: CGMCC No.30771.

[0007] The Bacillus Velez 14-NW of the present invention is screened and separated from the surface of K326 flue-cured tobacco leaves, and is more likely to form a dominant bacterial population in an environment containing TSNAs than other bacteria.

[0008] The Bacillus Velez 14-NW of the present invention can act on tobacco products to reduce the NNK content thereof in a targeted manner, and at most can completely degrade NNK in a targeted manner without introducing other harmful substances.

[0009] In a second aspect, the present invention provides a biological preparation, characterized in that it comprises the Bacillus Velezii 14-NW and / or its metabolic enzyme products as described above.

[0010] Furthermore, the biological preparation also includes molecular sieves.

[0011] Furthermore, the mass of the molecular sieve is 5% to 15% of the mass of the tobacco product.

[0012] In a specific embodiment, the mass of the molecular sieve is 10% of the mass of the tobacco product.

[0013] In some specific embodiments, the molecular sieve is artificial zeolite or natural zeolite, zeolite type 5A3, particle size 5 mm, pore size

[0014] In a specific embodiment, the molecular sieve is an artificial zeolite, zeolite type 5A3, particle size 5 mm, pore size

[0015] In a third aspect, the present invention provides a method for treating tobacco products, comprising: subjecting the Bacillus velezensis 14-NW and / or its metabolite products, or the biological agent of the present invention to the tobacco products.

[0016] Furthermore, the method further comprises adding 0.5% to 8% of the mass ratio of Bacillus Velez 14-NW to the tobacco product, and culturing at a constant temperature for more than 48 hours.

[0017] In some specific embodiments, Bacillus Velez 14-NW directedly degrades NNK in tobacco extract, and its access ratio is 0.5-3% by mass of the tobacco extract. Exemplarily, it can be 0.5%, 1%, 1.5%, 2%, 2.5%, 3%, or a value between any two ranges.

[0018] In some specific embodiments, Bacillus Velez 14-NW directedly degrades NNK in tobacco extract, and the culture time is 48-96 h. Exemplarily, it can be 48 h, 60 h, 72 h, 84 h, 96 h, or a value between any two ranges.

[0019] In some specific embodiments, Bacillus Velez 14-NW directionally degrades NNK in tobacco leaves, and its addition ratio is 2-8% of the mass ratio of tobacco leaves. Exemplarily, it can be 2%, 3%, 4%, 5%, 6%, 7%, 8%, or a value between any two ranges.

[0020] In some specific embodiments, Bacillus Velez 14-NW directionally degrades NNK in tobacco leaves, and the culture time is 15-25 days. Exemplarily, it can be 15 days, 16 days, 17 days, 18 days, 19 days, 20 days, 21 days, 22 days, 23 days, 24 days, 25 days, or a value between any two ranges.

[0021] Furthermore, the components of the culture medium for culturing the Bacillus Velez 14-NW include: yeast extract powder, potassium dihydrogen phosphate, dipotassium hydrogen phosphate, soy peptone, glucose, sodium chloride, magnesium sulfate, and NNK-D4 standard solution.

[0022] In some specific embodiments, the components of the culture medium include 0.1% to 1% yeast extract powder, 0.01% to 0.2% potassium dihydrogen phosphate, 0.01% to 0.2% dipotassium hydrogen phosphate, 0.1% to 1% soy peptone, 1% to 5% glucose, 0.9% sodium chloride, 0.01% to 0.2% magnesium sulfate, and 0.1% to 5% NNK-D4 standard solution.

[0023] In a specific embodiment, the components of the culture medium include 0.5% yeast extract powder, 0.1% potassium dihydrogen phosphate, 0.1% dipotassium hydrogen phosphate, 0.5% soy peptone, 2% glucose, 0.9% sodium chloride, 0.1% magnesium sulfate, and 1% NNK-D4 standard solution.

[0024] Furthermore, the tobacco product includes tobacco extract or tobacco leaves.

[0025] Furthermore, when the tobacco product is a tobacco extract, the method further comprises culturing the tobacco extract acted upon by Bacillus Velezii 14-NW and / or its metabolite enzyme products at 30-40° C., preferably 35° C., at 100-200 r / min.

[0026] Furthermore, when the tobacco product is tobacco leaves, the method further comprises culturing the tobacco leaves acted upon by Bacillus Velez 14-NW and / or its metabolite products at 30-40°C, preferably 35°C, and 60-70%, preferably 65% ​​humidity.

[0027] In a fourth aspect, the present invention provides a tobacco product obtained by subjecting the Bacillus Velezii 14-NW and / or its metabolite products described in the present invention to the tobacco product.

[0028] The present invention provides a tobacco product obtained by the tobacco product processing method as described above.

[0029] Furthermore, the NNK content in the tobacco product is ≤0.07 ng / 100 puffs.

[0030] In a fifth aspect, the present invention provides a use of the Bacillus Velezii 14-NW of the present invention for degrading NNK in tobacco products.

[0031] In a sixth aspect, the present invention provides an atomized liquid comprising the tobacco product of the present invention.

[0032] Furthermore, the tobacco product is tobacco extract or tobacco leaves. DETAILED DESCRIPTION

[0033] The present invention will be described in detail below in conjunction with specific embodiments and examples, and the advantages and various effects of the present invention will be more clearly presented. It should be understood by those skilled in the art that these specific embodiments and examples are used to illustrate the present invention, rather than to limit the present invention.

[0034] Culture medium: LB broth (Qingdao Haibo Biotechnology Co., Ltd.), nutrient agar (Qingdao Haibo Biotechnology Co., Ltd.), dipotassium hydrogen phosphate (Sinopharm Chemical Reagent Co., Ltd.), potassium dihydrogen phosphate (Sinopharm Chemical Reagent Co., Ltd.), sodium chloride (Sinopharm Chemical Reagent Co., Ltd.), magnesium sulfate (Sinopharm Chemical Reagent Co., Ltd.), sodium nitrite standard solution (Xiamen Anyongbo Technology Co., Ltd.), yeast extract powder (Qingdao Haibo Biotechnology Co., Ltd.), agar powder (Qingdao Haibo Biotechnology Co., Ltd.), soy peptone (Qingdao Haibo Biotechnology Co., Ltd.), glucose (Qingdao Haibo Biotechnology Co., Ltd.), NNK-D4 standard solution (Shanghai Keteng Chemical Technology Co., Ltd.), Gram staining solution (Qingdao Haibo Biotechnology Co., Ltd.), DNA extraction kit (Tiangen Biochemical Beijing Co., Ltd.).

[0035] Culture medium:

[0036] Physiological saline: 0.9% sodium chloride solution, sterilized at 121℃ for 20 minutes.

[0037] Enrichment medium: LB broth, nutrient agar, sterilized at 121℃ for 20min.

[0038] Nitrite liquid separation medium: yeast extract powder 0.5%, potassium dihydrogen phosphate 0.1%, dipotassium hydrogen phosphate 0.1%, soy peptone 0.5%, glucose 2%, sodium chloride 0.9%, magnesium sulfate 0.1%, sodium nitrite standard solution 0.2%, pH 6.8-7.4, sterilization at 121℃ for 20 minutes.

[0039] NNK liquid separation medium: yeast extract powder 0.5%, potassium dihydrogen phosphate 0.1%, dipotassium hydrogen phosphate 0.1%, soy peptone 0.5%, glucose 2%, sodium chloride 0.9%, magnesium sulfate 0.1%, NNK-D4 standard solution 1% (passed through 0.22 μm membrane), pH 6.8-7.4, sterilization at 121°C for 20 min.

[0040] NNK solid separation medium: yeast extract powder 0.5%, potassium dihydrogen phosphate 0.1%, dipotassium hydrogen phosphate 0.1%, soy peptone 0.5%, glucose 2%, sodium chloride 0.9%, magnesium sulfate 0.1%, agar powder 5%, NNK-D4 standard solution 1% (passed through 0.22 μm membrane), pH 6.8-7.4, sterilization at 121°C for 20 min.

[0041] The method for preparing the mixture of propylene glycol and glycerol in the present invention is as follows: propylene glycol: glycerol = 6:4 to 1:1 (mass ratio). The method for preparing 0.5% smoke oil in the present invention is as follows: 0.5% sample is added, and the rest is supplemented with the mixture of propylene glycol and glycerol.

[0042] The method for collecting TSNAs in tobacco shreds of the present invention is as follows: 0.5 g of tobacco shreds raw material is weighed into a centrifuge tube, and 10 ml of 0.1 mol / L ammonium acetate solution containing an internal standard (the internal standard is 40.0 ng / ml of NNK-d4, NNN-d4, NAB-d4 and NAT-d4), and ultrasonically extracted for 30 minutes, and then an appropriate amount of the extract is taken to pass through a 0.22 μm aqueous phase filter membrane and transferred to a chromatographic analysis bottle for HPLC-MS / MS analysis.

[0043] The method for collecting TSNAs in cigarette oil of the present invention is as follows: 0.1 g of cigarette oil sample is weighed into a centrifuge tube, and 2 ml of 0.1 mol / L ammonium acetate solution containing internal standards (the internal standards are 40.0 ng / ml of NNK-d4, NNN-d4, NAB-d4 and NAT-d4), and ultrasonic extraction is performed for 30 minutes. Then, an appropriate amount of the extract is taken and filtered through a 0.22 μm aqueous phase filter membrane, and the extract is transferred to a chromatographic analysis bottle for HPLC-MS / MS analysis.

[0044] The method for collecting TSNAs in flue gas of the present invention is as follows: a raw material sample is prepared into a cigarette cartridge, and the flue gas is smoked according to the standard of GB-41770, and the smoking parameters are: 55 ml, 30 s, 3 s, and 100 puffs, and then the flue gas is captured by two 44 mm glass fiber filters and placed in a conical flask, and 15 ml of 0.1 mol / L ammonium acetate solution containing an internal standard (the internal standard is 40.0 ng / ml of NNK-d4, NNN-d4, NAB-d4 and NAT-d4) is added, and the flue gas is placed on a shaker for 30 minutes for sufficient extraction, and then an appropriate amount of the extract is taken and filtered through a 0.22 μm aqueous phase filter membrane, and transferred to a chromatographic analysis bottle for HPLC-MS / MS analysis.

[0045] The present invention provides a method for determining TSNAs in a sample as follows: TSNAs are determined on HPLC-MS / MS (model: Thermo Fisher Orbitrap Exploris 120), and specific parameters are as follows: a chromatographic column is a Hypersil GOLDTM aQ 18 column (1.9 μm, 2.1 mm×100 mm); a mobile phase is a phase A of 0.1% formic acid and a phase B of 100 mmol of ammonium acetate solution; a flow rate is 0.2 ml / min; a column temperature is 35° C.; 2 μl is injected each time; an electrospray ionization source (ESI) is used as an ion source, and an electrospray voltage is 5000 V; a positive ion scan is used as a scanning mode, and a multiple reaction monitoring mode (MRM) is used as a detection mode. The final solution was quantified by the internal standard method. NNN, NNK, NAT and NAB standards (purity ≥ 98%) were prepared into a series of standard working solutions (the concentration gradients of NNN, NNK, NAT and NAB were 1.0, 2.0, 8.0, 20.0, 40.0, 80.0, 200 and 400 ng / mL, and the concentrations of the four internal standards were all 40.0 ng / ml), and the solutions were injected sequentially to draw a standard working curve with a correlation coefficient greater than or equal to 0.99. The calculation results of the working curve were used as the quantitative results.

[0046] Example 1: Isolation and screening of bacteria for directional degradation of NNK

[0047] Sample screening

[0048] According to the domestic tobacco leaf usage and distribution, Yunnan and Hubei, where the most tobacco leaves are grown, were selected for screening. Burley tobacco, flue-cured tobacco, and cigar tobacco were selected for screening. Since the accumulation of TSNAs is mostly concentrated in tobacco leaf storage and aging, tobacco leaves that were aged for 12-16 months after the initial baking were selected for separation and screening. The sample information is shown in Table 1 below.

[0049] Table 1. Tobacco leaf samples

[0050] Sample No.: Tobacco Varieties Aging time NG Flue-cured tobacco NC 13 months NW Flue-cured tobacco K326 14 months YN Flue-cured tobacco cloud 87 14 months ES Enshi Burley Tobacco 12 months XJ Hubei Cigars 12 months

[0051] Screening of bacteria for targeted degradation of NNK

[0052] Take the above tobacco varieties, tobacco leaves, tobacco stems, cut into pieces and put into sterile physiological saline, 35 ° C, 150r / min, culture for 30min, 35 ° C, 150r / min, culturing for 30min, take 1% of the liquid part, inoculate it into LB broth medium, 35 ° C, 150r / min, culture for 48h, the culture solution is greater than 1 at OD600, take 1% of the culture solution and inoculate it into nitrite liquid medium (yeast extract powder 0.5%, potassium dihydrogen phosphate 0.1%, potassium hydrogen phosphate 0.1%, soy peptone 0.5%, glucose 2%, sodium chloride 0.9%, magnesium sulfate 0.1%, sodium nitrite standard solution 0.2%, pH 6.8-7.4, 121 ° C sterilization for 20min), 35 ° C, 150r / min, culture for 48h, the culture solution is greater than 1 at OD600, dilute the bacterial solution by 10 -1 , 10 -2 , 10 -3 , 10 -4 , 10 -5 The bacterial solution with different dilution gradients was inoculated into NNK solid culture medium (0.5% yeast extract, 0.1% potassium dihydrogen phosphate, 0.1% dipotassium hydrogen phosphate, 0.5% soy peptone, 2% glucose, 0.9% sodium chloride, 0.1% magnesium sulfate, 5% agar powder, 1% NNK-D4 standard solution (passed through a 0.22 μm membrane), pH 6.8-7.4, sterilized at 121°C for 20 min) using the dilution spreading plate method, cultured at 35°C for 72 h, and single colonies grown on the plate were selected for NNK degradation test.

[0053] Single colonies of different morphologies grown on the NNK solid separation plate were picked and inoculated into NNK liquid separation medium (0.5% yeast extract, 0.1% potassium dihydrogen phosphate, 0.1% potassium hydrogen phosphate, 0.5% soy peptone, 2% glucose, 0.9% sodium chloride, 0.1% magnesium sulfate, 1% NNK-D4 standard solution (passed through a 0.22 μm membrane), pH 6.8-7.4, sterilized at 121°C for 20 min), cultured at 35°C, 150 r / min for 48 h, and after the culture was completed, centrifuged at 8000 r / min for 10 min, and the clear liquid was taken for NNK content detection (Table 2). The isolated strain NW-14 with the lowest NNK content was stored in a -80°C glycerol tube. The remaining strains in Table 2 are other bacteria screened from the same batch.

[0054] Table 2. Degradation of NNK by bacterial strains

[0055] Strain No. NNK degradation rate 16-NG 68.32% 14-NW 98.12% 02-YN 75.38% 16-ES 55% 69-XJ 70.03%

[0056] Example 2: Molecular Biological Identification of Bacillus Velezii 14-NW

[0057] The screened strain 14-NW was inoculated into LB broth medium and cultured at 35°C, 150r / min for 48h. At the end of the culture, the culture was centrifuged at 8000r / min for 10min, and the bacterial liquid was collected. The 16S rDNA gene was amplified by PCR using the 16S rDNA universal primer forward primer 36F to obtain the nucleotide sequence list.

[0058] The 16S rDNA gene fragment of strain 14-NW was amplified by PCR, purified and recovered, and DNA sequencing was completed by Beijing Qingke Biotechnology Co., Ltd. The measured sequence was analyzed for sequence similarity using the Blastn program of NCBI, and the 16S rDNA gene sequence of representative strains of similar species was selected from the Genbank database and the ribosome database. The homology analysis results of the sequenced directional degradation NNK efficient degradation bacteria 14-NW showed that the 16S rDNA gene sequence of strain 14-NW was highly similar to Bacillus velezensis, and the phylogenetic tree was constructed by MEGA7.0 software. The phylogenetic tree analysis showed that strain 14-NW belonged to Bacillus velezensis. Combined with the morphological characteristics and 16S rDNA gene sequence analysis, the strain was identified as Bacillus velezensis and named Bacillus velezensis 14-NW.

[0059] Example 3: Directed degradation of NNK in tobacco extract by Bacillus Velez 14-NW

[0060] The screened Bacillus Velez 14-NW was inoculated in LB broth medium and cultured at 35°C and 150r / min for 48h. The laboratory burley tobacco extract 1404R was diluted with 4 times the mass of water and sterilized at 121°C for 20min. After cooling, 1% Bacillus Velez 14-NW bacterial solution was inoculated and cultured at 35°C and 150r / min for 72h. After the culture was completed, it was filtered through a 600-mesh filter cloth and concentrated to a density of 1.1231±0.008. The blank control group was a laboratory burley tobacco extract 1404R diluted with 4 times the mass of water, sterilized at 121°C for 20min, inoculated with 1% sterile saline, cultured at 35°C and 150r / min for 72h, and filtered through a 600-mesh filter cloth to concentrate to a density of 1.1231±0.008. The treated samples and standard samples were prepared into 0.5% tobacco oil for detection. The NNK degradation rate is shown in Table 3, and the standard sample is the blank control. 1404R-NW is a sample treated with Bacillus Velez 14-NW. From the test data, it can be seen that the degradation rate of NNK by Bacillus Velez 14-NW in the laboratory burley tobacco extract 1404R reaches 100%, and the contents of other NNN, NAT, and NAB are not affected, indicating that the strain has the function of directional degradation of NNK. The NNK content of the product treated with the strain is 0, which meets the requirements of the product of the present invention.

[0061] Table 3. NNK degradation rate of Bacillus velez 14-NW in burley tobacco extract 1404R

[0062]

[0063] Example 4: Directed degradation of NNK in tobacco extract by Bacillus Velez 14-NW

[0064] The screened Bacillus Velez 14-NW was inoculated in LB broth medium and cultured at 35°C and 150r / min for 48h. The laboratory dry tobacco extract 7403Y was diluted with 4 times the mass of water and sterilized at 121°C for 20min. After cooling, 1% Bacillus Velez 14-NW bacterial solution was inoculated and cultured at 35°C and 150r / min for 72h. After the culture was completed, it was filtered through a 600-mesh filter cloth and concentrated to a density of 1.1231±0.008. The blank control group was a laboratory dry tobacco extract 7403Y diluted with 4 times the mass of water, sterilized at 121°C for 20min, inoculated with 1% sterile saline, cultured at 35°C and 150r / min for 72h, and filtered through a 600-mesh filter cloth to concentrate to a density of 1.1231±0.008. The treated samples and standard samples were prepared into 0.5% tobacco oil for detection. The NNK degradation rate is shown in Table 3, and the standard sample is the blank control. 1404R-NW is a sample treated with Bacillus Velez 14-NW. From the test data, it can be seen that the degradation rate of NNK by Bacillus Velez 14-NW in the laboratory dry tobacco extract 7403Y reaches 100%, and the contents of other NNN, NAT, and NAB are not affected, indicating that the strain has the function of directional degradation of NNK. The NNK content of the product treated with the strain is 0, which meets the requirements of the product of the present invention.

[0065] Table 4. NNK degradation rate of Bacillus velez 14-NW in tobacco extract 7403Y

[0066]

[0067] Example 5: Directed degradation of NNK in tobacco leaves by Bacillus Velez 14-NW

[0068] The screened Velez Bacillus 14-NW was inoculated in LB broth medium, cultured at 35°C and 150r / min for 48h, burley tobacco leaves were shredded, 5% Velez Bacillus 14-NW bacterial solution and 20% saline were evenly added using a spray feeder, and the mixture was placed in a constant temperature and humidity chamber at 35°C and 65% humidity for 20d. The blank control was burley tobacco leaves shredded, 20% saline was evenly added using a spray feeder, and the mixture was placed in a constant temperature and humidity chamber at 35°C and 65% humidity for 20d. The NNK degradation rate is shown in Table 4, the standard sample is the blank control, and BL-14 is a sample treated with Velez Bacillus 14-NW. From the test data, it can be seen that the degradation rate of NNK by Velez Bacillus 14-NW in burley tobacco leaves reaches 100%, and the remaining NNN, NAT, and NAB are not affected, indicating that the strain has the function of directional degradation of NNK, and the NNK content of the product treated by the strain is 0, which meets the product requirements of the present invention.

[0069] Table 5. NNK degradation rate of Bacillus Velez 14-NW in burley tobacco leaves

[0070]

Claims

1. A Bacillus velezensis 14-NW, characterized in that Its accession number is CGMCC No.30771.

2. A biological agent, characterized in that: The method comprises the Bacillus Velez 14-NW and / or its metabolic enzyme products as claimed in claim 1.

3. A method for treating tobacco products, characterized in that: include: The Bacillus Velez 14-NW of claim 1 and / or the biological agent of claim 2 are applied to tobacco products.

4. The method according to claim 3, characterized in that The method further comprises adding 0.5% to 8% of the mass ratio of Bacillus Velez 14-NW to the tobacco product, and culturing at a constant temperature for more than 48 hours.

5. The method according to claim 3 or 4, characterized in that: The method further comprises the steps of placing the tobacco extract acted upon by Bacillus 14-NW and / or its metabolites at 30-40°C and 100-200 r / min for cultivation when the tobacco product is a tobacco extract; and placing the tobacco leaves acted upon by Bacillus 14-NW and / or its metabolites at 30-40°C and 60-70% humidity for cultivation when the tobacco product is a tobacco leaf.

6. A tobacco product obtained by the tobacco product processing method according to any one of claims 3 to 5.

7. The tobacco product according to claim 6, characterized in that The NNK content in the tobacco product is ≤0.07 ng / 100 puffs.

8. Use of the Bacillus Velez 14-NW according to claim 1 and / or the biological preparation according to claim 2 for degrading NNK in tobacco products.

9. An atomized liquid, characterized in that: Comprising a tobacco product as claimed in claim 6 or 7.

10. The atomized liquid according to claim 9, characterized in that: The tobacco product is a tobacco extract.

Citation Information

Cited By

  • Bacillus velezensis DX-32 capable of efficiently degrading nitrite and TSNAs and application of bacillus velezensis DX-32

    CN116083293A

  • A strain of Bacillus Velezii DX-32 capable of efficiently degrading nitrite and TSNAs and its application

    CN116083293B